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Abstract
Correction to Genotypic detection of rifampicin and isoniazid resistant Mycobacterium
tuberculosis strains by DNA sequencing: a randomized trial Amina Abdelaal, Hassan Abd El-
Ghaffar, Mohammad Hosam Eldeen Zaghloul, Noha El mashad, Ehab Badran, Amal Fathy Annals of
Clinical Microbiology and Antimicrobials 2009, 8:4 (30 January 2009)
Correction
We lately discovered an accidental mistake, our manu-
script [1] needs some important corrections; we offer our
sincerest apologies and correct the text as under.
B.15.8 in sentence 2, asparagine is converted to aspartate.
B.15.11 in sentence 2, tyrosine is converted to threonine.
Table 9, asparagine is converted to aspartate, tyrosine is
converted to threonine.
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